BILVIAY Trademark

Trademark Overview

On Monday, February 5, 2018, a trademark application was filed for BILVIAY with the United States Patent and Trademark Office. The USPTO has given the BILVIAY trademark a serial number of 87783792. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 2, 2025. This trademark is owned by Albireo AB. The BILVIAY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical product for the treatment of liver and gastrointestinal diseases and disorders
bilviay

General Information

Serial Number87783792
Word MarkBILVIAY
Filing DateMonday, February 5, 2018
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 2, 2025
Registration Number5584399
Registration DateTuesday, October 16, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2018

Trademark Statements

Goods and ServicesPharmaceutical product for the treatment of liver and gastrointestinal diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 2, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlbireo AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGöteborg 41346
SE
Party NameAlbireo AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGöteborg
SE
Party NameAlbireo AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGöteborg
SE

Trademark Events

Event DateEvent Description
Thursday, February 8, 2018NEW APPLICATION ENTERED
Monday, April 30, 2018ASSIGNED TO EXAMINER
Monday, April 30, 2018NON-FINAL ACTION E-MAILED
Tuesday, February 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 30, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 6, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, June 20, 2018ASSIGNED TO LIE
Monday, April 30, 2018NON-FINAL ACTION WRITTEN
Friday, May 25, 2018EXAMINERS AMENDMENT E-MAILED
Friday, May 25, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 25, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, May 25, 2018EXAMINER'S AMENDMENT ENTERED
Friday, May 25, 2018SUSPENSION LETTER WRITTEN
Friday, May 25, 2018LETTER OF SUSPENSION E-MAILED
Friday, May 25, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, June 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Tuesday, July 31, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 22, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 16, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, July 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 23, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 23, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, March 23, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 23, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 23, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 23, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 16, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 2, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

bilviay diseases disorders gastrointestinal liver product treatment pharmaceutical